Jackson Creek Investment Advisors LLC Axonics, Inc. Transaction History

Jackson Creek Investment Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$49.38 - $63.75 $493 - $637	-10 Reduced 0.07%	14,058 $875,000
Q3 2023 Nov 03, 2023	SELL	$48.64 - $62.51 $389 - $500	-8 Reduced 0.06%	14,068 $789,000
Q2 2023 Aug 02, 2023	BUY	$47.99 - $60.21 $44,054 - $55,272	918 Added 6.98%	14,076 $710,000
Q1 2023 May 02, 2023	SELL	$52.6 - $67.34 $315 - $404	-6 Reduced 0.05%	13,158 $718,000
Q4 2022 Feb 03, 2023	SELL	$59.56 - $76.6 $39,130 - $50,326	-657 Reduced 4.75%	13,164 $823,000
Q3 2022 Nov 09, 2022	BUY	$57.96 - $78.12 $801,065 - $1.08 Million	13,821 New	13,821 $974,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.